Developing a molecular marker for metachronous colorectal cancer

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Metachronous colorectal cancer (CRC) poses a significant clinical challenge.
• Identifying individuals at high risk for developing secondary CRC is crucial for improved patient outcomes.

Purpose of the Study:

• To investigate the prevalence of microsatellite instability (MSI) in patients with metachronous colorectal cancer.
• To evaluate MSI as a potential biomarker for identifying individuals at increased risk of developing metachronous CRC.

Main Methods:

• Analysis of 37 colorectal tumors from 18 patients with metachronous CRC.
• Investigation of five microsatellite loci using single-stranded conformational polymorphism (SSCP) analysis.
• Definition of MSI as new polymerase chain reaction (PCR) bands compared to normal mucosa.

Main Results:

• Successful PCR amplification was achieved in 27 out of 37 metachronous cancer specimens.
• Microsatellite instability was detected in 59.3% (16/27) of the metachronous tumors analyzed.
• No MSI was observed in the control group of 11 individuals with sporadic colorectal cancer.

Conclusions:

• The findings indicate a strong association between MSI and the development of metachronous colorectal cancer.
• Individuals with MSI in their primary colorectal tumors exhibit a heightened risk for developing secondary colorectal cancers.
• MSI serves as a potential predictive marker for identifying high-risk individuals susceptible to metachronous CRC.